Clinical trial Recruiting at 5 sites Interventional Ages 18 and up

Custom 3D-printed dynamic titanium implants to rebuild the chest wall

Official title: "Multicenter Registry for Chest Wall Reconstruction Surgery Using Custom Dynamic Prostheses PRODIPET"

Run by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · NCT07018960 · Data updated 2026-11-12

This study tests custom 3D-printed dynamic titanium implants to rebuild the chest wall and help adults who need reconstruction after tumor removal or severe chest trauma breathe more comfortably and have less pain.

More Post Traumatic Stress Disorder trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorFundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
Academic / other
Drugs / interventionsradiation
Locations5 sites (Cruces, Basque Country and 4 other locations)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedDecember 2025
Study endsDecember 2025
Registry record updatedAugust 12, 2025
Trial IDNCT07018960 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) who require chest wall reconstruction for oncologic resection, severe trauma, or post-infection/post-radiation defects involving at least two ribs or the sternum with a defect ≥5 cm and who are planned for reconstruction with a custom 3D-printed titanium prosthesis are ideal candidates.

Probably not a fit

Patients with active systemic infection, severe uncorrectable cardiopulmonary disease (e.g., FEV1 <30% predicted), inadequate soft-tissue coverage, or complex vertebral involvement are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

PRODIPET is a multicenter ambispective registry combining retrospective cases and new patients enrolled prospectively over a 24-month window, with each patient followed for 12 months. Participating centers use preoperative CT-based planning to design patient-specific Ti6Al4V implants manufactured by additive manufacturing and engineered to allow physiological rib movement. The registry collects standardized clinical outcomes including pain, respiratory function, complication rates, and imaging follow-up to characterize short- and mid-term safety and function. Final pooled analysis is planned after all patients complete 12 months of follow-up.

Why it matters

Potential benefit: If successful, these personalized dynamic implants could improve chest wall mechanics, reduce pain, and enhance breathing and quality of life compared with rigid reconstructions.

How similar studies have gone: Small case series and single-center reports have shown promising functional and safety results with custom 3D-printed titanium chest wall implants, but large multicenter comparative data remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

Patients must meet ALL of the following:

• Age: ≥18 years

Clinical Indication:

* Requires chest wall reconstruction due to:
* Oncologic resection (primary tumors, metastases)
* Traumatic injury (flail chest, severe rib fractures)
* Post-infection/post-radiation defects
* Defect Characteristics:
* Involves ≥2 ribs or sternum with instability
* Minimum defect size: 5 cm in largest dimension
* Surgical Plan:
* Scheduled for reconstruction with 3D-printed custom titanium prosthesis
* Consent: Willing to provide informed consent for:
* Surgery
* Data collection
* Follow-up evaluations
* Exclusion Criteria

Patients will be excluded if ANY of the following apply:

* Medical Contraindications:
* Active systemic infection (e.g., sepsis)
* Severe cardiopulmonary disease (FEV₁ \<30% predicted)
* Uncorrectable coagulopathy (INR \>1.5)
* Technical Limitations:
* Inadequate soft tissue coverage for prosthesis
* Vertebral column involvement requiring complex fixation
* Material Incompatibility:
* Known hypersensitivity to titanium alloys
* Study Logistics:
* Participation in another conflicting clinical trial
* Inability to complete follow-up (e.g., no fixed address)
* Ethical Considerations:
* Pregnancy (due to elective CT scan requirements)
* Prisoners or cognitively impaired patients without legal guardians

Where it's running

  • Hospital de Cruces
    Cruces, Basque Country, Spain
    Recruiting
  • Complejo Hospitalario Universitario Insular
    Las Palmas de Gran Canaria, Canary Islands, Spain
    Recruiting
  • Hospital Universitario Josep Trueta
    Barcelona, Catalonia, Spain
    Recruiting
  • Hospital Universitario Ramón y Cajal
    Madrid, Madrid, Spain
    Recruiting
  • Hospital Universitario de La Ribera
    Alzira, Valencia, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.